Correlation Between Merck and Agios Pharm
Can any of the company-specific risk be diversified away by investing in both Merck and Agios Pharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and Agios Pharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck Company and Agios Pharm, you can compare the effects of market volatilities on Merck and Agios Pharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of Agios Pharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and Agios Pharm.
Diversification Opportunities for Merck and Agios Pharm
0.4 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Merck and Agios is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and Agios Pharm in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Agios Pharm and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with Agios Pharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Agios Pharm has no effect on the direction of Merck i.e., Merck and Agios Pharm go up and down completely randomly.
Pair Corralation between Merck and Agios Pharm
Considering the 90-day investment horizon Merck Company is expected to under-perform the Agios Pharm. In addition to that, Merck is 1.32 times more volatile than Agios Pharm. It trades about -0.16 of its total potential returns per unit of risk. Agios Pharm is currently generating about 0.06 per unit of volatility. If you would invest 3,375 in Agios Pharm on November 28, 2024 and sell it today you would earn a total of 69.00 from holding Agios Pharm or generate 2.04% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Merck Company vs. Agios Pharm
Performance |
Timeline |
Merck Company |
Agios Pharm |
Merck and Agios Pharm Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Merck and Agios Pharm
The main advantage of trading using opposite Merck and Agios Pharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, Agios Pharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agios Pharm will offset losses from the drop in Agios Pharm's long position.The idea behind Merck Company and Agios Pharm pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Agios Pharm vs. Mereo BioPharma Group | Agios Pharm vs. Blueprint Medicines Corp | Agios Pharm vs. Day One Biopharmaceuticals | Agios Pharm vs. Biomarin Pharmaceutical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
CEOs Directory Screen CEOs from public companies around the world | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |